September 5, 2017 / 2:52 PM / 3 months ago

BRIEF-Novocure says German Federal Joint Committee supports Optune trial

Sept 5 (Reuters) - Novocure Ltd:

* German Federal Joint Committee published decision to support clinical trial studying optune for treatment of newly diagnosed glioblastoma​

* Novocure and G-BA will share costs for conduct of clinical trial

* German Ministry of Health approval process, subsequent initiation of clinical trial anticipated to take up to additional 18 months, longer

* Co ‍will continue to bill German healthcare payers for individual cases till the German Ministry of Health approval process​ takes place Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below